Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation

Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine Against Community-Acquired Pneumonia in the General Population Aged >=60 Years: 3 Years of Follow-up in the CAPAMIS Study

(2014) O. Ochoa-Gondar et al.   CLINICAL INFECTIOUS DISEASES

The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: Results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study

(2014) Timothy L. Wiemken et al.   VACCINE

Cross-Sectional Study on Attitudes among General Practitioners towards Pneumococcal Vaccination for Middle-Aged and Elderly Population in Hong Kong

(2013) Lancelot W. H. Mui et al.   PLoS One

Interventions to Improve Influenza and Pneumococcal Vaccination Rates Among Community-Dwelling Adults: A Systematic Review and Meta-Analysis

(2012) D. Lau et al.   ANNALS OF FAMILY MEDICINE

The development of 13-valent pneumococcal conjugate vaccine and its possible use in adults

(2011) Robert W Frenck et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Pneumococcal Polysaccharide Vaccination Among Adults Aged 65 Years and Older, U.S., 1989–2008

(2010) Peng-jun Lu et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Factors associated with pneumococcal and influenza vaccination in hospitalized people aged ⩾65 years

(2010) X. SINTES et al.   EPIDEMIOLOGY AND INFECTION

Efficacy of pneumococcal vaccination in adults: a meta-analysis

(2009) A. Huss et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL